CN100408080C - Heart quieting and orifice opening capsule and its preparation - Google Patents

Heart quieting and orifice opening capsule and its preparation Download PDF

Info

Publication number
CN100408080C
CN100408080C CNB031371302A CN03137130A CN100408080C CN 100408080 C CN100408080 C CN 100408080C CN B031371302 A CNB031371302 A CN B031371302A CN 03137130 A CN03137130 A CN 03137130A CN 100408080 C CN100408080 C CN 100408080C
Authority
CN
China
Prior art keywords
grams
gram
radix
capsule
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031371302A
Other languages
Chinese (zh)
Other versions
CN1513519A (en
Inventor
郑淑英
李平安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB031371302A priority Critical patent/CN100408080C/en
Publication of CN1513519A publication Critical patent/CN1513519A/en
Application granted granted Critical
Publication of CN100408080C publication Critical patent/CN100408080C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a novel heart calming and resuscitation inducement capsule which is a Chinese patent medicine for treating schizophrenosis and a preparation method thereof. The novel heart calming and resuscitation inducement capsule takes mica colorata, eaglewood, artificial bezoar, coptis, scutellaria root, gardenia, rhubarb, curcuma aromatica salisb, antelope's horn, radix gentianae, senega, grassleaved sweetflag rhizome, licorice root and tabasheer as raw material. Pretreatment, such as superfine grinding, solvent extraction, etc. is respectively carried out according to the different characteristics of each traditional Chinese medicine. The material is proportionally prepared, subsequently ripened, sterilized and made into particles, and the capsule is obtained after the particles are filled into a capsule. A formulation and the preparation method of the present invention are novel. The clinical use of more than one hundred patients with psychonosema, such as schizophrenosis shows that the effect is ideal.

Description

A kind of treatment schizophrenia drug and preparation method thereof
The present invention relates to schizoid medicine of a kind of treatment and preparation method thereof, is the Chinese patent medicine that raw material is made with the Chinese herbal medicine specifically, the invention still further relates to the manufacture method of this medicine.
The schizophrenia traditional Chinese medical science belongs to demented, is the frequently-occurring disease of serious harm human health, and China's prevalence is at present: the inferior crowd of economic level is 10.16 ‰, and economic level is first-class to be 4.75 ‰.Account for China psychosis inpatients people's about 50%, account for chronic mental illness people's about 60%, the primary disease frequently-occurring disease also is the common psychosis the closest with criminal behavior in person between twenty and fifty.
The general unconscious and disturbance of intelligence of schizophrenia, normal performance have the inharmonious of the obstacle of aspects such as special thinking, consciousness, emotion and behavior and ergasia and environment.The cause of disease of primary disease and pathogeny, treatment and prevention are the central topics of psychiatry research tackling key problem always.Just, run into the problem of the following aspects both at home and abroad to schizoid Drug therapy:
1, based on the Western medicine chlorpromazine be the medicine of representative, be 8~10 weeks the general course of treatment, though respond well, more obvious to cardiovascular and liver function influence, dosage is also bigger.
2, folklore the schizoid folk prescription of many treatments, generally all is the alkaloids Chinese medicine of the inhibition nervus centralis of single or two to three flavors, and bone marrow is had excitation more.
Though 3 also have some to treat schizoid Chinese patent medicine, because Time of Administration is longer, effect is not fairly obvious, injures taste, and the patient still depends on some Western medicine.
The object of the present invention is to provide a kind of effect of eliminating the phlegm by flat contrary, the suppressing the hyperactive liver to relieve the wind syndrome of drink, sending down the abnormal ascending QI, clearing away heat-fire, tranquillizing and allaying excitement that has, it is less to take the back side effect, and effect is sure, the treatment of schizophrenia medicament for the treatment of both the principal and secondary aspects of a disease.
Another object of the present invention provides a kind of preparation method for the treatment of schizophrenia drug.
Solution of the present invention is based on Chinese medicine and pharmacy to schizoid etiology and pathology understanding and Therapeutic Principle, with reference to the modern scientific research achievement, from Chinese herbal medicine, filter out and having the natural Chinese medicine that eliminates the phlegm by flat contrary, the suppressing the hyperactive liver to relieve the wind syndrome of drink, sending down the abnormal ascending QI, clearing away heat-fire, tranquillizing and allaying excitement, according to theory of Chinese medical science, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, make it bring into play the collaborative opsonic action of all medicines, prevent and treat schizoid the development.
A kind of schizophrenia drug for the treatment of of the present invention is made by following prescription and weight:
Lapis Micae Aureus 300 gram Lignum Aquilariae Resinatum 100 gram Rhizoma Coptidis 200 gram Radix Scutellariaes 200 gram artificial Calculus Boviss 50 grams
Fructus Gardeniae 300 gram Radix Et Rhizoma Rhei 200 gram Radix Polygalaes 300 gram Radix Glycyrrhizaes 50 cron Radix Gentianae 200 grams
Radix Curcumae 200 gram Cornu Saigae Tataricae 150 gram Rhizoma Acori Graminei 300 gram Concretio silicea Bambusae seu schizostachyi 200 grams.
The method that above-mentioned each proportioning Chinese herbal medicine is made medicine of the present invention is: after earlier Lapis Micae Aureus 300 grams, artificial Calculus Bovis's 50 grams, Cornu Saigae Tataricae 150 grams, Concretio silicea Bambusae seu schizostachyi 200 grams being cleaned, it is standby to be crushed to 300 mesh sieve impalpable powders; Lignum Aquilariae Resinatum 100 grams, Rhizoma Coptidis 200 grams, Radix Scutellariae 200 grams, Radix Polygalae 300 grams, Radix Glycyrrhizae 50 grams, Radix Gentianae 200 grams, Radix Curcumae 200 grams, Rhizoma Acori Graminei 300 grams, Fructus Gardeniae 300 grams, Radix Et Rhizoma Rhei 200 gram waters are decocted three times, 2 hours for the first time, second and third time each 1 hour, three filtrates are mixed, heating is condensed into thick paste and above-mentioned standby fine powder mixing, detect, ripening under 100~110 ℃ of temperature, sterilization 20~40 minutes, spray is made soft material with 45% ethanol, be pressed through screen cloth No. 1, the Capsules shell of packing into after the drying is made capsule.
Characteristics of the present invention are that medicament is easy to use, have no side effect, and can see positive effect in a short time.The animal acute toxicity test of medicine of the present invention is as follows:
Test unit: institute for drug control, Zhengzhou City pharmacological room
Date of test: on June 23,16 days to 1998 June in 1998
Result of the test: calming heart for resuscitation capsule mice once-a-day, the maximum tolerated dose of gastric infusion is 1333.3g (crude drug)/kg, is equivalent to 400.4 times with dosage of clinical plan.Animal activity, outward appearance sign after the administration, cut open inspection and there is no unusually, feces is black, and normal, body weight gain is normal, no dead animal.The body weight determination of mice mtd test the results are shown in Table 1.
The body weight determination of table 1 calming heart for resuscitation capsule mice mtd test
Figure C0313713000051
Annotate: X ± SD n=20
Medicine of the present invention carries out the observation treatment of overall process to 108 routine inpatients, wherein male 62 examples, and women 46 examples, the oldest person 60 years old, reckling 16 years old is cured 92 people that leave hospital, produce effects 16 people, total effective rate reaches 100%.Therapeutic outcome sees Table 2
Table 2 calming heart for resuscitation capsule for treating 108 routine patient's observation of curative effect
Figure C0313713000052
Test statistics shows: medicine of the present invention is to schizophrenia and acute psychogenic mental disorder best results.
Medicine of the present invention is by clinical application practice, and is useful to patients such as schizophrenia, removed human spirit's obstacle, demonstrates wide practical prospect and potentiality to be exploited.

Claims (3)

1. treat schizophrenia drug for one kind, it is characterized in that it is the medicament of being made by following herbal raw material proportioning:
Lapis Micae Aureus 300 gram Lignum Aquilariae Resinatum 100 gram Rhizoma Coptidis 200 gram Radix Scutellariaes 200 gram artificial Calculus Boviss 50 grams
Fructus Gardeniae 300 gram Radix Et Rhizoma Rhei 200 gram Radix Polygalaes 300 gram Radix Glycyrrhizaes 50 cron Radix Gentianae 200 grams
Radix Curcumae 200 gram Cornu Saigae Tataricae 150 gram Rhizoma Acori Graminei 300 gram Concretio silicea Bambusae seu schizostachyi 200 grams.
2. a kind of treatment schizophrenia drug according to claim 1 is characterized in that said medicament is a capsule.
3. one kind prepares aforesaid right requirement 1 or 2 described a kind of preparation methoies for the treatment of schizophrenia drug, after it is characterized in that earlier Lapis Micae Aureus 300 grams, artificial Calculus Bovis's 50 grams, Cornu Saigae Tataricae 150 grams, Concretio silicea Bambusae seu schizostachyi 200 grams being cleaned, it is standby to be crushed to 300 mesh sieve impalpable powders; Lignum Aquilariae Resinatum 100 grams, Rhizoma Coptidis 200 grams, Radix Scutellariae 200 grams, Radix Polygalae 300 grams, Radix Glycyrrhizae 50 grams, Radix Gentianae 200 grams, Radix Curcumae 200 grams, Rhizoma Acori Graminei 300 grams, Radix Et Rhizoma Rhei 200 grams, Fructus Gardeniae 300 gram waters are decocted three times, 2 hours for the first time, second and third time each 1 hour, three filtrates are mixed, heating is condensed into thick paste and above-mentioned standby fine powder mixing, detect, ripening under 100~110 ℃ of temperature, sterilization 20~40 minutes, spray is made soft material with 45% ethanol, be pressed through screen cloth No. 1, the Capsules shell of packing into after the drying is made capsule.
CNB031371302A 2003-06-04 2003-06-04 Heart quieting and orifice opening capsule and its preparation Expired - Fee Related CN100408080C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031371302A CN100408080C (en) 2003-06-04 2003-06-04 Heart quieting and orifice opening capsule and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031371302A CN100408080C (en) 2003-06-04 2003-06-04 Heart quieting and orifice opening capsule and its preparation

Publications (2)

Publication Number Publication Date
CN1513519A CN1513519A (en) 2004-07-21
CN100408080C true CN100408080C (en) 2008-08-06

Family

ID=34240105

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031371302A Expired - Fee Related CN100408080C (en) 2003-06-04 2003-06-04 Heart quieting and orifice opening capsule and its preparation

Country Status (1)

Country Link
CN (1) CN100408080C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579511B (en) * 2009-07-02 2011-08-31 陈雪梅 Drug combination used for treating schizophrenia
CN102526381A (en) * 2010-12-27 2012-07-04 黑龙江康元神经专科医院有限责任公司 Traditional Chinese medicine preparation for treating schizophrenia
CN102302734B (en) * 2011-08-30 2013-01-16 高新华 Agent for treating insomnia
CN102657786B (en) * 2012-03-22 2013-07-03 翟爱玲 Drinking potion for treating mania
CN103272190A (en) * 2013-06-24 2013-09-04 陈焕微 Chinese herbal compound for curing invasion of pericardium by evil, sleep talking and delirious speech
CN103285266B (en) * 2013-07-02 2014-09-10 李伟丽 Chinese medicine composition for treating schizophrenia
CN106620544A (en) * 2017-03-07 2017-05-10 李子义 Medicine for treating schizophrenia and preparation method of medicine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1382473A (en) * 2002-05-21 2002-12-04 崔行善 Medicine for treating psychic diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1382473A (en) * 2002-05-21 2002-12-04 崔行善 Medicine for treating psychic diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中药在癫痫病治疗中的应用. 朱秀罗.河南中医药学刊,第10卷第4期. 1995
中药在癫痫病治疗中的应用. 朱秀罗.河南中医药学刊,第10卷第4期. 1995 *

Also Published As

Publication number Publication date
CN1513519A (en) 2004-07-21

Similar Documents

Publication Publication Date Title
CN101028507A (en) Chinese-medicinal composition for treating asthma
CN103550532B (en) Traditional Chinese medicine (TCM) composition for treating palpitation
CN104338062A (en) Chinese medicinal preparation for treating stomachache and diarrhea
CN103405697A (en) Medicament for treating pulmonary tuberculosis
CN102210820A (en) Chinese medicinal composition for treating leukemia
CN100408080C (en) Heart quieting and orifice opening capsule and its preparation
CN105031454A (en) Medicine for treating pulmonary tuberculosis
CN104888131A (en) Traditional Chinese medicine composition for treatment of insomnia
CN102579720B (en) Medicament for treating facial paralysis and preparation method thereof
CN103784768A (en) Traditional Chinese medicine composition for treating palpitation
CN105288116A (en) Traditional Chinese medicine composition for treating schizophrenia
CN103127480A (en) Drug for curing constipation
CN102861289B (en) Chinese medicinal drug addiction stopping and three-hyper lowering capsule
CN102793868B (en) Preparation method of traditional Chinese medicine lotion for treating rapid respiration type closed fracture
CN104758588A (en) Traditional Chinese medicine composition for treating dizziness
CN104758578A (en) Traditional Chinese medicine composition for treating palpitation
CN109453324A (en) A kind of preparation method for the reason spleen stomach function regulating Traditional Chinese medicine formula preparation that clears liver
CN104324188A (en) Traditional Chinese medicine composition for treating childhood tourette syndrome and preparation method thereof
CN103520588B (en) A kind of drug rehabilitation herbal composite
CN103520419B (en) Medicine for treating globus hysteriocus and preparation method thereof
CN101317989B (en) Pure traditional Chinese medicine medicament composition for treating white plague
CN107617091A (en) A kind of Chinese medicine composition for treating cold asthma
CN101829213B (en) Medicine composition for treating asthma and preparation method thereof
CN101224295A (en) Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof
CN106581468A (en) Preparation method of traditional Chinese medicine capable of treating gastric ulcer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080806